Huh. They’re guiding for 15% per annum profit growth for the next five years. (Independent of new drug approvals)
- Forums
- ASX - By Stock
- CSL
- Ann: Top-line Results from the Phase 3 AEGIS-II Trial
CSL
csl limited
Add to My Watchlist
2.94%
!
$255.70

Ann: Top-line Results from the Phase 3 AEGIS-II Trial, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$255.70 |
Change
7.310(2.94%) |
Mkt cap ! $122.7B |
Open | High | Low | Value | Volume |
$252.00 | $256.17 | $251.10 | $206.3M | 799.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 16 | $255.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$255.69 | 12 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65 | 255.700 |
1 | 7 | 255.690 |
4 | 53 | 255.670 |
2 | 29 | 255.640 |
1 | 6 | 255.630 |
Price($) | Vol. | No. |
---|---|---|
255.730 | 236 | 3 |
255.740 | 17 | 2 |
255.750 | 3 | 1 |
255.760 | 27 | 2 |
255.770 | 41 | 3 |
Last trade - 11.41am 18/07/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |